Study Links Loss of E-Cadherin to Estrogen-Driven Melanoma Metastasis in Women

Researchers at Institut Curie have uncovered a molecular pathway that appears to drive melanoma metastasis in women. The study identifies a connection between the loss of E-cadherin, estrogen receptor-α (ERα), and gastrin-releasing peptide receptor (GRPR), which collectively contribute to the progression of melanoma in female patients. This discovery highlights sex-specific differences in cancer biology and may hold implications for treatment strategies targeting female cancers.

The findings suggest that the absence of E-cadherin, a protein involved in cell adhesion, triggers changes linked to ERα and GRPR activity. These molecular interactions are associated with an increased likelihood of melanoma spreading in women compared to men. Researchers emphasize the significance of this pathway in understanding why certain cancers behave differently based on sex. Further investigation into these mechanisms could inform future therapeutic approaches tailored specifically to female patients battling melanoma or other estrogen-related cancers.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 23, 2025

Author

Mark Chiang